These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6629144)

  • 41. Evaluation of natural coagulation inhibitor levels in various hypertensive states of pregnancy.
    Sayin M; Varol FG; Sayin NC
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):183-7. PubMed ID: 15893867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amniotic fluid and cord plasma erythropoietin levels in pregnancies complicated by preeclampsia, pregnancy-induced hypertension and chronic hypertension.
    Teramo KA; Hiilesmaa VK; Schwartz R; Clemons GK; Widness JA
    J Perinat Med; 2004; 32(3):240-7. PubMed ID: 15188798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases.
    Petraglia F; Luisi S; Benedetto C; Zonca M; Florio P; Casarosa E; Volpe A; Bernasconi S; Genazzani AR
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2991-5. PubMed ID: 9284732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coagulation inhibitors in preeclamptic pregnant women.
    Osmanağaoğlu MA; Topçuoğlu K; Ozeren M; Bozkaya H
    Arch Gynecol Obstet; 2005 Mar; 271(3):227-30. PubMed ID: 14735372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.
    Bosio PM; Wheeler T; Anthony F; Conroy R; O'herlihy C; McKenna P
    Am J Obstet Gynecol; 2001 Jan; 184(2):146-52. PubMed ID: 11174494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antithrombin III in pregnancy-induced hypertensive diseases].
    Sitte B; Schröcksnadel H; Steckel-Berger G; Dapunt O
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():153-4. PubMed ID: 1286333
    [No Abstract]   [Full Text] [Related]  

  • 47. Serum levels of alpha-tocopherol in hypertensive pregnancies.
    Valsecchi L; Cairone R; Castiglioni MT; Almirante GM; Ferrari A
    Hypertens Pregnancy; 1999; 18(3):189-95. PubMed ID: 10586522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prorenin concentration in the hypertensive disorders in pregnancy.
    de León RG; de Melián EM; Coviello A; De Vito E
    Hypertens Pregnancy; 2001; 20(2):157-68. PubMed ID: 12044326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibronectin and antithrombin as markers of pre-eclampsia in pregnancy.
    Paternoster DM; Stella A; Simioni P; Girolami A; Plebani M
    Eur J Obstet Gynecol Reprod Biol; 1996 Dec; 70(1):33-9. PubMed ID: 9031918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prevalence of pre-eclampsia and obstetric outcome in pregnancies of normotensive and hypertensive women attending a hospital specialist clinic.
    Lydakis C; Beevers M; Beevers DG; Lip GY
    Int J Clin Pract; 2001; 55(6):361-7. PubMed ID: 11501223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antithrombin III level in normal pregnancy and patients with pregnancy-induced hypertension].
    During R; Schwarzlos G
    Zentralbl Gynakol; 1990; 112(6):351-4. PubMed ID: 2371798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mononuclear cell magnesium content remains unchanged in various hypertensive disorders of pregnancy.
    Frenkel Y; Weiss M; Shefi M; Lusky A; Mashiach S; Dolev E
    Gynecol Obstet Invest; 1994; 38(4):220-2. PubMed ID: 7851804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies.
    Higgins JR; Walshe JJ; Darling MR; Norris L; Bonnar J
    Am J Obstet Gynecol; 1998 Aug; 179(2):520-6. PubMed ID: 9731863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antithrombin-III in preeclampsia-eclampsia. Pilot study].
    Verduzco Rodríguez L; González Puebla E; López Ariza B; Manffrini Madrid F
    Ginecol Obstet Mex; 1998 Aug; 66():343-6. PubMed ID: 9745197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia.
    Shinyama H; Akira T; Uchida T; Hirahara K; Watanabe M; Kagitani Y
    J Cardiovasc Pharmacol; 1996 May; 27(5):702-11. PubMed ID: 8859941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoreactive circulating endothelin-1 in normal and hypertensive pregnancies.
    Schiff E; Ben-Baruch G; Peleg E; Rosenthal T; Alcalay M; Devir M; Mashiach S
    Am J Obstet Gynecol; 1992 Feb; 166(2):624-8. PubMed ID: 1536245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [PlGF and sFlt-1--diagnostic significance in preeclampsia prediction in pregnant women with gestational and chronic hypertension].
    Manolov V; Marinov B; Vasilev V
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():61-9. PubMed ID: 24294749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antithrombin III and preeclampsia.
    Brenner B
    Isr J Med Sci; 1990 Mar; 26(3):121-2. PubMed ID: 2329033
    [No Abstract]   [Full Text] [Related]  

  • 59. Heparin cofactor activity and antithrombin III antigen levels in preeclampsia.
    Friedman KD; Borok Z; Owen J
    Thromb Res; 1986 Aug; 43(4):409-16. PubMed ID: 3764801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma glutathione S-transferase Pi 1-1 measurements in the study of hemolysis in hypertensive disorders of pregnancy.
    Knapen MF; Peters WH; Mulder TP; Merkus HM; Jansen JB; Steegers EA
    Hypertens Pregnancy; 1999; 18(2):147-56. PubMed ID: 10476616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.